Here are relevant reports on : ultrasound-market
-
Europe Contrast Media Market by Product (Microbubble, Iodine, Gadolinium, Barium-based), Modality (CT, MRI, Ultrasound), Indication (Cancer, GIT, CVD, Musculoskeletal, Neurology, Urology), Route of Administration (IV, Oral), End User - Forecast to 2031
The Europe contrast media market is projected to reach USD 3.19 billion by 2031, growing at a CAGR of 7.5% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Electrophysiology Market by Product (Lab Devices (3D Mapping, Recording, ICE, X-ray Systems), Ablation Catheters (Cryoablation, Radiofrequency, Laser, Microwave), Diagnostic Catheters (Conventional, Advanced, Ultrasound)), End Use-Global Forecast to 2030
The global electrophysiology market, valued at US$11.41 billion in 2024, stood at US$12.55 billion in 2025 and is projected to advance at a resilient CAGR of 11.6% from 2025 to 2030, culminating in a forecasted valuation of US$21.72 billion by the end of the period. The rise of the electrophysiology market can be attributed to several drivers: the increasing prevalence of cardiovascular diseases, including arrhythmias and atrial fibrillation; patients and healthcare providers are increasingly favoring minimally invasive procedures over traditional surgical interventions; electrophysiological techniques, such as catheter ablation, offer less invasive options for treating certain cardiac arrhythmias; and government support and initiatives aimed at improving healthcare infrastructure and funding research and development in electrophysiology also contribute to market growth.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Interventional Radiology Imaging Market by Product (MRI System, Ultrasound Imaging System, CT Scanner, Angiography System), Procedures (Angiography, Angioplasty, Biopsy) & Application (Cardiology, Oncology, Urology & Nephrology) - Global Forecast to 2021
The global interventional radiology imaging market is projected to grow at a CAGR of 6.7%. This market is segmented based on product, procedure, and application. A number of factors, such as rising incidence and prevalence of chronic diseases, increasing demand for minimally invasive procedures, technological advancements are expected to drive the growth of this market.
- Published: March 2017
- Price: $ 4950
- TOC Available:
-
Non Invasive Prenatal Testing Market by Product (Consumables, Reagent, Ultrasound, NGS, PCR, Microarray), Services, Method (cfDNA, Biochemical Markers), Application (Aneuploidy, Microdeletion) & End-User (Hospital, Labs) - Global Forecasts to 2029
The global non invasive prenatal testing market, valued at US$6.4 billion in 2023, stood at US$7.2 billion in 2024 and is projected to advance at a resilient CAGR of 14.5% from 2024 to 2029, culminating in a forecasted valuation of US$14.1 billion by the end of the period. The primary growth factors propelling this market include spiking investments, incentives, and support from both state governments and private companies, which are driving access to and demand for NIPT technologies.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Womens Health Diagnostics Market by Application (Biopsy, Cervical & Ovarian Cancer Testing, PAP Smear, HPV, TORCH, Prenatal Testing, Hepatitis, Ultrasound, Obstetrics), End User (Hospitals, Clinics, Home Care) & Region - Global Forecast to 2025
The global womens health diagnostics market growth is primed to transition from $25.0 billion in 2020 to $36.6 billion by 2025, showcasing a strong CAGR of 7.9%. The market growth is mainly driven by growing awareness about various health-related disorders, rising incidence of chronic and lifestyle disorders, and the high prevalence of infectious diseases such as HIV and hepatitis in women across the globe.
- Published: February 2021
- Price: $ 4950
- TOC Available:
-
Non-Thermal Processing Market for Food by Technology (HPP, PEF, Irradiation, Ultrasound, Cold Plasma), Food Type (Meat, Beverages), Function (Microbial Inactivation, Quality Assurance), and Region - Global Forecast to 2022
The global market for non-thermal processing market has grown exponentially in the last few years. The market is estimated to be valued at USD 818.6 Million in 2017, and is projected to reach USD 1,224.2 Million by 2022, at a CAGR of around 8.4% from 2017. Emerging economies such as India, China, and Brazil are the potential primary markets of the industry. Growing trend of novel technologies and process optimizaiton are driving the market for non-thermal processing. This report includes a study of business strategies, along with the product portfolios of leading companies. More than 160 developments were tracked for the 15 companies in the non-thermal processing market. It includes the profiles of leading companies such as Bosch (Germany), Bühler (Switzerland), Hiperbaric España (Spain), Nordion (Canada), Avure Technologies (US), Emerson (US), CHIC FresherTech (US), Elea Technology (Germany), Pulsemaster (Netherlands), Gray*Star (US), Dukane (US), and Symbios Technologies (US).
- Published: March 2018
- Price: $ 4950
- TOC Available:
-
Thrombectomy Devices Market by Type (Hydrodynamic, Ultrasound, Aspiration, Mechanical Thrombectomy), Application (Cardiovascular, Peripheral, Neurovascular), End User (Hospitals, Surgical Centers, Ambulatory, Academia, CROs)- Global Forecast to 2022
The global thrombectomy devices market is projected to grow at a CAGR of 6.7% . Some of the prominent players in the market are Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), Johnson & Johnson (U.S.), Terumo Corporation (Japan), Penumbra, Inc. (U.S.), Spectranetics Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), Argon Medical Devices, Inc. (U.S.), and Teleflex Incorporated (U.S.), were few other key players operating in the market.
- Published: April 2017
- Price: $ 4950
- TOC Available:
-
Blood Flow Measurement Devices Market by Product (Ultrasound (Transit Time Flow Meter), Laser Doppler), Application (Invasive (CABG, Microvascular Surgery), Non-invasive (Cardiovascular, Gastroenterology & Tumor Monitoring)) - Global Forecast to 2021
The blood flow measurement devices market is projected to grow at a CAGR of 9.2%. The growth of the overall blood flow measurement devices market can be contributed to the growing prevalence of cardiovascular diseases and diabetes coupled with rising geriatric population, technological advancements, and the influx of VC funding.
- Published: March 2017
- Price: $ 4950
- TOC Available:
-
Ophthalmic Imaging Market by Product Type (Optical Coherence Tomography Systems, Ophthalmic Ultrasound Systems, Fundus Cameras), Application (Glaucoma, Retinopathies), End User (Hospitals, Ophthalmology Clinics, Optometry Clinics) - Global Forecast to 2030
The global ophthalmic imaging market, valued at US$2.7 billion in 2024, stood at US$2.8 billion in 2025 and is projected to advance at a resilient CAGR of 6.3% from 2025 to 2030, culminating in a forecasted valuation of US$3.8 billion by the end of the period. The ophthalmic imaging market is driven by the rising prevalence of eye diseases and an aging global population, which boosts demand for advanced diagnostic tools.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Neurodiagnostics Market by Product (Diagnostic & Imaging Systems (MRI, Ultrasound), Clinical Testing (PCR, NGS), Reagents & Consumables), Disease Pathology (Epilepsy, Stroke), End User and Region - Global Forecasts to 2024
The neurodiagnostics market is projected to reach USD 8.4 billion by 2024, at a CAGR of 7.3%. Some of the prominent players in this market includes GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Hitachi, Ltd. (Japan), Canon, Inc. (Japan), Lifelines Neuro Company, LLC (US), Natus Medical Incorporated (US), Hoffman-La Roche AG (Switzerland), FUJIFILM Holdings Corporation (Japan), Mitsar Co., Ltd. (Russia), Advanced Brain Monitoring (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories (US), QIAGEN N.V. (Netherlands), Nihon Kohden Corporation (Japan), ANT Neuro (Netherlands), Fonar Corporation (US), Fujirebio (Japan), DRG Instruments GmbH (Germany), Tecan Trading AG (Switzerland), Motion Lab Systems, Inc. (US), Rigaku Corporation (Japan), Neusoft Medical Systems Co., Ltd. (US), ELMIKO MEDICAL Sp. Z o.o. (Poland) and Ridge Diagnostics (US).
- Published: December 2019
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50